Since September 2025, COFEPRIS's new Abbreviated Pathway has opened a faster, more accessible route to market for manufacturers who already hold approvals from major regulatory bodies like the FDA, CE, Health Canada, and others. Instead of navigating a lengthy full technical review, you can now leverage your existing approvals to dramatically cut submission time and complexity. This guide breaks down everything you need to know — from eligibility requirements and device classification to documentation, timelines, and how to appoint a Mexico Registration Holder.
On September 1, 2025, COFEPRIS’s new Abbreviated Pathway for medical devices and IVDs went into effect and became the primary regulatory route to Mexico. This new pathway makes registration more accessible and efficient for devices and IVDs with prior authorizations in most major device markets. If you were hesitant about pursing COFEPRIS registration before, thinking it would be too expensive, time consuming, or labor intensive, you can now leverage your existing approvals for significantly less submission preparation time.
In this article, we will cover everything you need to know about how to register medical devices and IVDs in Mexico, including how to qualify for the Abbreviated Pathway, submission requirements, review timelines, and more.
Medical devices and IVDs distributed in Mexico are regulated by the Federal Commission for Protection against Sanitary Risks (COFEPRIS). COFEPRIS develops regulations, Normas Oficiales Mexicanas (NOMs), guidelines, and public announcements in the Federal Register, which is similar to the Official Journal of the European Union. The Regulation of Health Supplies is the regulation that covers regulatory requirements for medical devices and IVDs.
NOMs dictate specific quality and safety requirements for medical devices and IVDs. Three of the most relevant NOMs are:
Most medical devices and IVDs require pre-market authorization (also called sanitary registration) from COFEPRIS before supplying devices in Mexico. This requires submitting documentation about your device to COFEPRIS for review. On approval, COFEPRIS issues a sanitary registration number, which must appear on your device labeling.
COFPERIS has two main regulatory pathways: standard pathway and abbreviated (equivalency) pathway:
Standard Pathway requires full technical review of your technical documentation, labeling, safety, and clinical information by COFEPRIS. Review timelines can vary widely based on your device classification and complexity of the review, not to mention the volume of submissions COFEPRIS is managing at the time of submission.
Abbreviated Pathway is an equivalency review pathway in which COFEPRIS grants expedited authorization based on prior approval from a recognized reference authority. Reference authorities accepted for abbreviated review include approvals from IMDRF and MDSAP member markets may be leveraged, including FDA, EU CE marking (MDD, IVDD, MDR, IVDR), Health Canada, Swissmedic, ANVISA, TGA, MFDS, NMPA, and other ICH-, WHO-, IMDRF-, or MDSAP-recognized bodies.
Approval in an accepted reference market does not guarantee eligibility for the abbreviated pathway. The device submitted to COFEPRIS must be identical to the device approved in the reference market in terms of intended use and performance. The reference approval must be no more than five years old, and the device must have a clean safety history (no recalls or safety alerts). Any changes to manufacturer names or sites may also rule out the abbreviated pathway option.
Some of the steps required for the Mexico medical device registration process include:
You must comply with COFEPRIS’s rigorous post-market surveillance and vigilance requirements to maintain the validity of your registrations. However, this article will focus on pre-market registration requirements.
Medical device classification rules are published in the Mexican Pharmacopeia (Farmacopea de los Estados Unidos Mexicanos or FEUM) and are based on the International Medical Device Regulators Forum (IMDRF) and Medical Devices Directive MDD 93/42/EEC. New rules added in 2023 brought the classification scheme in closer alignment with the EU Medical Device Regulation (EU MDR).
There are three main classification tiers with an additional category for very low risk devices:
Low-risk devices require sanitary registration, but COFEPRIS review time is expedited relative to other classes. As stated, some listed low-risk devices can be marketed without sanitary registration if you maintain an appropriate QMS and meet all post-market monitoring and technovigilance requirements.
The Pharmacopoeia includes separate rules specific to IVDs. IVDs are classified into three risk tiers according to individual and public health risk:
All foreign manufacturers need an MRH to sell medical devices and IVDs in Mexico. This relationship must be established through a formal agreement, and you must include a Letter of Representation with your submission. The MRH is a person or entity located in Mexico who legally represents your company to COFEPRIS during the sanitary registration process. The MRH is responsible for submitting the registration dossier to COFEPRIS, managing the approved registration, and adding or removing distributors from the sanitary registration. Your MRH partner should be very knowledgeable about COFEPRIS requirements and verify that your submission complies with their expectations.
The MRH is named on the device labeling as the legal sanitary registration owner, making them accountable for ensuring compliance with post-market requirements on behalf of the foreign manufacturer. For this reason, it is best to separate the MRH and distributor roles. This separation allows you to freely manage distributors, proactively maintain post-market compliance obligations, and renew registrations without conflicts of interest.
In addition to your MRH, you will also need an importer of record, a distributor with a compliant warehouse, and a customs broker to bring your devices into Mexico. These agents facilitate compliance with labeling, storage, post-market surveillance, and customs requirements in collaboration with your MRH. Technical agreements that outline the roles and responsibilities of each party are required.
COFEPRIS requires proof that your company and manufacturing facilities comply with Good Manufacturing Practice (GMP) requirements. Several forms of quality management system (QMS) evidence are accepted, including:
All documents must be original or certified copies provided in Spanish or English with a certified translation if the original document is in another language. Physical documents must be apostilled or legalized in the country of origin (electronic documents are authenticated via the issuing agency’s website).
Exact documentation requirements vary by device class. Lower risk devices require minimal documentation while higher risk devices can require extensive clinical evidence, including clinical trials, and risk management files to ISO 14971. However, the following documents are needed for most applications.
Core documents required for all applications:
COFEPRIS review timelines vary by device classification and registration pathway. The agency has historically struggled with backlogs and long review times but has taken steps to address this with harmonization and is now publishing aggressively shorter review timelines:
Approximate COFEPRIS Review Timelines for Standard Pathway:
Approximate COFEPRIS Review Timeline for Abbreviated Pathway:
The above timelines are only targets. Actual timelines can vary based on submission quality, classification, and complexity, as well as COFEPRIS’s submission volume.
Realistic review times for COFEPRIS submissions are:
For manufacturers already holding approval from a recognized international regulatory authority, Mexico's Abbreviated Pathway offers a significantly faster route to market. That said, Abbreviated registration is not a simple copy and paste process. Gaps in documentation can still create delays. And you need to appoint an experienced MRH for representative and on-the-ground regulatory support in Mexico. Pure Global's team in Mexico has deep expertise in COFEPRIS medical device registration and can act as your MRH, all for a flat annual fee.
Contact us to talk to an expert.
Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us